Publications by authors named "Masato Horikawa"

Claim this Profile
S
Simple chitin-based cell culture platform for production of biopharmaceuticals.
Katsuhiko Kida, Daisuke Hatanaka, Masataka Minami, Taiyo Suzuki, Masashi Iwakami, Masato Horikawa

Biotechnol Lett· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel 3D Culture System Using a Chitin-Based Polysaccharide Material Produces High-Quality Allogeneic Human UCMSCs with Dispersed Sphere Morphology.
Katsuhiko Kida, Tatsuro Kanaki, Shuang Gao, Daisuke Hatanaka, Masashi Iwakami, Masato Horikawa

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A miniature dialysis-culture device allows high-density human-induced pluripotent stem cells expansion from growth factor accumulation.
Fuad Gandhi Torizal, Qiao You Lau, Masato Ibuki, Yoshikazu Kawai, Masato Horikawa

Commun Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellhesion VP enhances the immunomodulating potential of human mesenchymal stem cell-derived extracellular vesicles.
Eun Seo Kim, Katsuhiko Kida, Jongsoo Mok, Yeonwoo Seong, Seo Yeon Jo, Masato Horikawa

Biomaterials· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of human induced pluripotent stem cells against shear stress in suspension culture by Bingham plastic fluid.
Ikki Horiguchi, Fuad Gandhi Torizal, Hotaka Nagate, Haruka Inose, Kousuke Inamura, Masato Horikawa

Biotechnol Prog· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maturational Characterization of Mouse Cortical Neurons Three-Dimensionally Cultured in Functional Polymer FP001-Containing Medium.
Noritaka Nakamichi, Yuta Matsumoto, Takumi Kawanishi, Takahiro Ishimoto, Yusuke Masuo, Masato Horikawa

Biol Pharm Bull· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of novel platelet-increasing agent eltrombopag with rosuvastatin via breast cancer resistance protein in humans.
Kazuya Takeuchi, Tomoko Sugiura, Kazuki Matsubara, Ren Sato, Takuya Shimizu, Masato Horikawa

Drug Metab Dispos· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Kazuya Takeuchi, Tomoko Sugiura, Saki Umeda, Kazuki Matsubara, Masato Horikawa

Drug Metab Dispos· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes.
Motohiro Kato, Koji Chiba, Masato Horikawa, Yuichi Sugiyama

Drug Metab Pharmacokinet· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.
Masato Horikawa, Yukio Kato, Charles A Tyson, Yuichi Sugiyama

Drug Metab Pharmacokinet· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans.
Masato Horikawa, Yukio Kato, Charles A Tyson, Yuichi Sugiyama

Drug Metab Pharmacokinet· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?
Kiyomi Ito, Koji Chiba, Masato Horikawa, Michi Ishigami, Naomi Mizuno

AAPS PharmSci· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in rats.
Masato Horikawa, Yukio Kato, Yuichi Sugiyama

Pharm Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis